Boardroom Alpha
Boardroom Alpha
CSGP · Current Report (Form 8-K) · Filed February 13, 2026

Costar Group Inc — Current Report (Form 8-K)

Form
8-K
Filed
February 13, 2026
Period
Feb 13, 2026
Ticker
CSGP
Accession
0001057352-26-000008
Boardroom Alpha · Filing insights

CoStar amends the Executive Severance Plan to remove the board-composition Change in Control clause to avoid litigation from proxy contests.

About Costar Group Inc
Market cap
$13.7B
1Y TSR
−57.8%
3Y TSR
−26.5%
Board grade
C
Sector
Real Estate
CEO
Andrew C Florance
Last annual meeting: Jun 23, 2026 · View full Costar Group Inc profile →
csgp-20260213

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 13, 2026
COSTAR GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
0-24531
52-2091509
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
1201 Wilson Blvd.Arlington,VA22209
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (202) 346-6500
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:  
Title of each classTrading SymbolName of each exchange on which registered
Common Stock ($0.01 par value)CSGPNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o











Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 13, 2026, CoStar Group, Inc., a Delaware corporation (“CoStar Group” or the “Company”), amended the CoStar Group Inc. Executive Severance Plan (as amended, the “Amended Severance Plan”) to remove a clause from the definition of “Change in Control” (the “director clause”) relating to the composition of the Board of Directors of the Company (the “Board”). All other terms and provisions of the Amended Severance Plan remain unchanged and in full force and effect.

The director clause was designed in consultation with the Compensation Committee of the Board’s (the “Compensation Committee”) independent compensation consultant and other advisors to protect management continuity at the Company, and is comparable to executive severance programs across the Company’s peer group. The Executive Severance Plan was unanimously approved by the Board and the Compensation Committee, and the Board and the Compensation Committee strongly believe that the director clause was in the best interest of the Company. However, the Board, at the request of management, determined to remove the director clause in order to avoid the unnecessary cost and distraction that would have resulted from an opportunistic lawsuit brought in Delaware that sought to advance misleading narratives arising from threatened proxy contests by Third Point LLC and D. E. Shaw & Co., L.P.

The foregoing description of the Amended Severance Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended Severance Plan, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.


Item 9.01     Financial Statements and Exhibits.

Exhibit No.Description
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
COSTAR GROUP, INC.
By: /s/ Christian M. Lown
Date:February 13, 2026Name: Christian M. Lown
Title: Chief Financial Officer

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Costar Group Inc (CSGP)

Reference

Frequently asked questions

When did Costar Group Inc file this 8-K?
Costar Group Inc (CSGP) filed this Current Report (Form 8-K) with the SEC on February 13, 2026. The accession number assigned by EDGAR is 0001057352-26-000008.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CoStar amends the Executive Severance Plan to remove the board-composition Change in Control clause to avoid litigation from proxy contests. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Costar Group Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Costar Group Inc has filed under CIK 1057352, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer